Detalhe da pesquisa
1.
Deep targeted sequencing of TP53 in chronic lymphocytic leukemia: clinical impact at diagnosis and at time of treatment.
Haematologica
; 104(4): 789-796, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30514802
2.
The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity.
Hum Mutat
; 39(5): 729-741, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29460995
3.
A Danish national effort of BRCA1/2 variant classification.
Acta Oncol
; 57(1): 159-162, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29168416
4.
Genomic profiling of newly diagnosed glioblastoma patients and its potential for clinical utility - a prospective, translational study.
Mol Oncol
; 14(11): 2727-2743, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32885540
5.
Circulating tumor DNA as a marker of treatment response in BRAF V600E mutated non-melanoma solid tumors.
Oncotarget
; 9(66): 32570-32579, 2018 Aug 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-30220966
6.
Importance of Comprehensive Molecular Profiling for Clinical Outcome in Children With Recurrent Cancer.
Front Pediatr
; 6: 114, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29732366
7.
Next-Generation Sequencing-Based Detection of Germline Copy Number Variations in BRCA1/BRCA2: Validation of a One-Step Diagnostic Workflow.
J Mol Diagn
; 19(6): 809-816, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28822785